Trends Rising Demand for Weight Management Solutions Advancements in Drug Formulations Integration of Digital Health Technologies Opportunities Innovations in Drug Delivery Systems Increasing Prevalence of Obesity and Diabetes Rising Investment in Diabetes and Obesity Research GLP-1 Drug Market Summary The Global GLP-1 Drug Market size was valued at USD 10.77 Billion in 2024, and the market is projected to grow from USD 12.19 Billion in 2025 to USD 42.0 Billion by 2035, registering a CAGR of 13.17% during the forecast period 20252035
Gut microbiota-derived TMAO: a causal factor promoting atherosclerotic cardiovascular disease
10.7150/thno.18290 184 WangY.TranK.YaoZ
In addition, recent exploratory studies have found increased serum BDNF levels following holistic neuro-rehabilitative approaches, including computer-assisted cognitive enhancement in schizophrenia 20 , aerobic exercise in stroke 21 and mindfulness clinical trials in bipolar-disorder 22
CrossRef The unconventional role of vimentin intermediate filaments Xinyi Huang, Shuangshuang Zhao, Yifan Xing, Xuedi Gao, Chenglin Miao, Yuhan Huang, Yaming Jiu Current Opinion in Cell Biology.2025
These results suggest that metabolic reprogramming in fibrotic fibroblasts is heavily dependent on glucose-derived glycine synthesis
